SAVE THE DATE – HTID – Health Investor Day – Sondage à remplir avant le 14 mars

 In Actualités

Health Investor Day – Sondage à remplir avant le 14 mars

 

Medicen Paris Region s’associe à France Biotech dans l’organisation du HealthTech Investor Day à Paris. Placé sous le haut patronage du Président de la République, cet évènement se tiendra pour la première fois le 25 juin prochain avec le soutien de l’écosystème français et européen. Le HTID (www.htid-paris.com) est une journée qui compte rassembler des investisseurs français, européens mais aussi américains et asiatiques pour des 1×1 meetings avec les C-level executives des sociétés de la healthtech (françaises et européennes), ainsi qu’avec la présence de sociétés pharmaceutiques.

 

Si vous etes interessé par l’évènement, merci remplir le sondage en suivant le lien ici, avant le 14 mars en fonction de vos réponses, nous reviendrons vers vous durant le mois d’avril.

 

Plus d’information

 


 

 

France Biotech and all the French and European health innovation ecosystem is organizing the 1st HealthTech Investor Day in Paris, under the High Patronage of Mr Emmanuel Macron, President of the French Republic. This event will take place in the Peninsula palace the 25th of June – www.htid-paris.com.

This business event aims to connect leading investors (European, American and Asian), pharmaceuticals companies and top management from French and European innovative companies in HealthTech; making the city of Paris a European place for business meetings.

This event is organized for private and listed companies willing to address leading investors and looking to raise funds. This event is targeting European innovative companies in HealthTech (biotech, medtech, digital-health) with a market-cap starting from €20 million (listed biotech companies), and on-going Phase 2 (private one). Regarding medtech companies, this event targets companies with CE or FDA approved product. The fees amount to €1500 for members of France Biotech and €1900 for non-members (Wondering if you are a member? Please check here: http://www.france-biotech.fr/membres-france-biotech/)

This event includes:

  • One-on-one meetings between innovative HealthTech companies and investors from French, European, American and Asian hedge funds, VC, banks for near and long-term investment,
  • One-on-one partnering meetings with international pharmaceuticals companies (for companies and investors),
  • Conferences and thematic panel discussions on specific topics supervised by well-known international scientific patronage and Nobel Prize winner :
  • France & Europe attractivity (speakers from Business France, BPIFrance and EuropaBio);
  • Economy & Finance (speakers from the Nasdaq and Euronext);
  • Importance of a BD strategy in the development of a HealthTech company (BDC Lifesciences);
  • Promote France’s Strengths on Health Innovation (LIR Association);
  • Hot topic in Oncology : After autologous CAR-T and Anti-PD1 / anti PD-L1 … what’s next?
  • Glamorous event will take place along the event with special guests.

 

If you are interested, please complete the survey hereafter before 14th of March and we will get back to you in April regarding your application: http://bit.ly/HTIDapplication

 

For more information, please do not hesitate to contact Sophie Villedieu, Business Manager & US Communications at France Biotech sophie.villedieu@france-biotech.org +33 (0)6 64 27 32 25 with the assistance of Nathalie Donne in the organizationnathalie.donne@shapenlink.com

Recommended Posts

Commenter cette actualité

Start typing and press Enter to search